ArticleAmerican journal of respiratory cell and molecular biology2014

Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.

James A Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.